Product Development
Development
Commercialization
- Support and brokerage in product portfolio optimization
Clinical Trials

Study set-up

Study conduct

CSR writing / preparation

Full service Clinical Research Organization

PhV in Clinical Trials
Quality
CMC development
- Nitrosamines
Technology and analytical methods
- Analytical Methods Transfer
GMP system
- GMP system implementation
GxP Audits
GMP
- GMP Audits (remote and on site)
- Audit of manufacturing sites/ laboratory
GCP
- GCP Audits (remote and on site)
PhV
- GVP Audits (remote and on site)
GLP
- GLP Audits (remote and on site)
Regulatory Affairs
Pre-authorisation
- Scientific Advice
- Product information
  
  Preparation of product information
  
  Bridging Report
  
  Package Leaflet readability test
  
  Translation of Patient Information
- Dossier preparation
  
  Medical writing - preparation of registration dossier
  
  CTD Module 3 - Quality
  
  Product information
  
  Enviromental Risk Assessment (ERA)
MA Handling
- Handling of the registration process
Post-authorisation
Regulatory outsourcing

Pharmaceutical law consulting
Pharmacovigilance
PhV system
- Pharmacovigilance system (PSMF)
- RMP Development and maintenance
PhV post-authorisation
Clinical trials
EU QPPV service
QP Service / Importer

QP Service

Import and supply chain management

MIA Certificate

RFI

MENU

pl
en

SciencePharma/

News & Insights

/ Blog /

Dopuszczenie do obro...

Dopuszczenie do obrotu dla produktu Neoparin Multi

Z przyjemnością informujemy, że SciencePharma uzyskała pozwolenie na dopuszczenie do obrotu dla produktu Neoparin Multi (Enoxaparinum natricum).

http://www.sciencepharma.zaler.pl/pl/neoparin

RETURN